BIB241220C35000
- 0.00
- 0.000.00%
Ultra Nasdaq Biotechnology Proshares Newsroom
MicroStrategy, Palantir, Axon Added To Nasdaq 100: Super Micro Computer, Moderna, Illumina Exit The Index
Weekly Buzz: Tech stocks hit high scores on ominous day
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
"Weight-Loss Drug Craze Appears To Be Curbing U.S. Obesity Epidemic; Obesity Is Down In The U.S. For The First Time In A Decade. A New Study Suggests Weight-Loss Drugs May Explain Why" - Bloomberg News
United Kingdom's National Health Service Drug Spending Priorities Questioned in New Analysis
Market Mixed on Friday the 13th | Livestock
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
Gilead Sciences Says Committee For Medicinal Products For Human Use Of European Medicines Agency Recommends Seladelpar For Treatment Of Primary Biliary Cholangitis In Combination With Ursodeoxycholic Acid (UDCA) In Adults With Inadequate Response To...
Vir Gets FDA Breakthrough Therapy Status for Two Drugs
Thursday Ends in Index Declines | Wall Street Today
Unpacking the Latest Options Trading Trends in Amgen
Tracer Biotechnologies Announces Multi-Year Project With AstraZeneca
Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing
Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock
AstraZeneca, Merck Report Positive Long-term Data for Lynparza
10 Health Care Stocks Whale Activity In Today's Session
Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
This D.R. Horton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Illumina Analyst Ratings
BofA Restarts Coverage of 11 Large-cap Biopharmas